The unexpected presence of iron in bone biopsies of hemodialysis patients

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
INTERNATIONAL UROLOGY AND NEPHROLOGY, v.50, n.10, p.1907-1912, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose Bone biopsy defines classical diseases that constitute the renal osteodystrophy. There is a recent concern regarding other histological findings that are not appreciated by using the turnover, mineralization, and volume (TMV) classification. Iron (Fe) overload has been considered a new challenge and the real significance of the presence of this metal in bones is not completely elucidated. Therefore, the main goal of the current study was to not only to identify bone Fe, but also correlate its presence with demographic, and biochemical characteristics. Methods This is a cross-sectional analysis of bone biopsies performed in 604 patients on dialysis from 2010 to 2014 in a tertiary academic Hospital. Results Histomorphometric findings revealed the presence of Fe in 29.1%. Fe was associated with higher levels of serum ferritin and serum calcium. No TMV status was related to Fe bone overload. Conclusion Our study has highlighted that the presence of Fe in one-third of bone samples has unknown clinical significance. The lack of other contemporary bone biopsy study reporting Fe prevents us from comparison. The findings presented here should be specifically addressed in a future research and will require attention prior to implementation of any clinical guideline. If any proposed treatment, however, would change the bone Fe-related morbidity is undetermined.
Palavras-chave
Bone biopsy, Iron, Dialysis, Histomorphometry, Ferritin
Referências
  1. Araujo SMHA, 2003, KIDNEY INT, V63, pS54, DOI 10.1046/j.1523-1755.63.s85.13.x
  2. Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062
  3. Barreto DV, 2008, AM J KIDNEY DIS, V52, P1139, DOI 10.1053/j.ajkd.2008.06.024
  4. Behets GJ, 2015, KIDNEY INT, V87, P846, DOI 10.1038/ki.2014.349
  5. Carvalho AB, 2013, J BONE MINER METAB, V31, P551, DOI 10.1007/s00774-013-0442-0
  6. Charytan DM, 2015, J AM SOC NEPHROL, V26, P1238, DOI 10.1681/ASN.2014090922
  7. DEVERNEJOUL MC, 1982, J CLIN ENDOCR METAB, V54, P276
  8. Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4
  9. Eleftheriadis T, 2014, INT UROL NEPHROL, V46, P161, DOI 10.1007/s11255-013-0497-9
  10. Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159
  11. GRATWICK GM, 1978, ANN INTERN MED, V88, P494, DOI 10.7326/0003-4819-88-4-494
  12. Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004
  13. He YF, 2013, BIOL TRACE ELEM RES, V152, P292, DOI 10.1007/s12011-013-9605-z
  14. Hernandez JD, 2008, CLIN J AM SOC NEPHRO, V3, pS164, DOI 10.2215/CJN.00460107
  15. Jorgetti V, 2000, AM J MED SCI, V320, P76, DOI 10.1097/00000441-200008000-00002
  16. Karohl C, 2010, NEPHROL DIAL TRANSPL, V25, P1244, DOI 10.1093/ndt/gfp597
  17. London GM, 2015, J AM SOC NEPHROL, V26, P476, DOI 10.1681/ASN.2014020169
  18. Malluche HH, 2011, J BONE MINER RES, V26, P1368, DOI 10.1002/jbmr.309
  19. Messer JG, 2009, BONE, V45, P972, DOI 10.1016/j.bone.2009.07.073
  20. Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414
  21. Moe SM, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.189
  22. PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
  23. PHELPS KR, 1988, AM J MED, V84, P775, DOI 10.1016/0002-9343(88)90119-2
  24. PIERIDES AM, 1984, NEW ENGL J MED, V310, P323
  25. Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001
  26. Pimentel A, 2017, KIDNEY INT, V92, P1343, DOI 10.1016/j.kint.2017.07.021
  27. Qu ZH, 2008, BIOCHEM BIOPH RES CO, V370, P332, DOI 10.1016/j.bbrc.2008.03.092
  28. Rocha LA, 2009, CLIN J AM SOC NEPHRO, V4, P105, DOI 10.2215/CJN.01630408
  29. Torres PU, 2014, SEMIN NEPHROL, V34, P612, DOI 10.1016/j.semnephrol.2014.09.004
  30. Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083
  31. Valenti L, 2009, OSTEOPOROSIS INT, V20, P549, DOI 10.1007/s00198-008-0701-4
  32. VEDI S, 1984, METAB BONE DIS RELAT, V5, P69, DOI 10.1016/0221-8747(83)90004-8
  33. Yamamoto S, 2012, INTERNAL MED, V51, P2375, DOI 10.2169/internalmedicine.51.7450
  34. Yamasaki K, 2009, TOXICOL LETT, V191, P211, DOI 10.1016/j.toxlet.2009.08.023
  35. Zarjou A, 2010, J BONE MINER RES, V25, P164, DOI 10.1359/jbmr.091002